NEW YORK, May 27, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that the Company will join the small-cap Russell 2000®...
Read More Details
Finally We wish PressBee provided you with enough information of ( Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes )
Also on site :
- Amazon Is Selling a 'Lovely' $70 Patio Umbrella for Only $30, and Shoppers Love That It’s 'Weather-Resistant'
- Two Minors Admit to Felony Charges following Bomb and Shooting Threat at Ventura High School
- Israel ‘Activated Clans’ to Fight Hamas in Gaza, Netanyahu Says